A recent study showed that activation of the PI3K/Akt signalling pathway might be involved in steroid resistance in COPD [57]; thus, ISO can be considered as a potential drug for corticosteroid-resistant COPD. This evidence concerns the gene AKT1 and chronic obstructive pulmonary disease.